BridgeMD
New treatment option for Neurogenic Bladder Disorder
Official title Define Final Selection Choice Criteria for a Coloplast Catheter Ensuring Highest Patient Satisfaction Via Surveys (EVA).
ClinicalTrials.gov ID: NCT07355803
What this study is testing
- What it's testing
- Understanding the Coloplast Intermittent Catheter Selection Study: This study aims to understand how adults who need to use catheters to empty their bladder by themselves decide which Coloplast catheter works best for them. The two types of catheters studied are called SpeediCath and Luja.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Female or male aged eighteen years or older;
- Written informed consent;
- Subject affiliated with a social security scheme or beneficiary;
- Subject with neurogenic or non-neurogenic bladder issues, justifying the implementation of intermittent self-catheterisation (ISC) to clean out the...
- Subject who received his/her initial ISC training at the time of inclusion;
You likely can't join if
- Vulnerable subject with regard to the current regulation:
- Pregnant, parturient or breast-feeding woman;
- Subject deprived of freedom by judicial, medical or administrative decision;
- Underage subject;
- Subject is legally protected or unable to express his/her consent;
- Subject not affiliated with or not a beneficiary of a social security scheme;
See the full eligibility criteria
- Female or male aged eighteen years or older;
- Written informed consent;
- Subject affiliated with a social security scheme or beneficiary;
- Subject with neurogenic or non-neurogenic bladder issues, justifying the implementation of intermittent self-catheterisation (ISC) to clean out the bladder;
- Subject who received his/her initial ISC training at the time of inclusion;
- Subject for whom the expected ISC duration is at least six months;
- Subject for whom at least two types of Coloplast catheters have been introduced and who has chosen to use Coloplast catheters as the first catheter for self-catheterisation;
- Subject able to independently conduct ISC;
- Subject for whom the healthcare professional has recommended to conduct ISC at least four times per day.
- Vulnerable subject with regard to the current regulation:
- Pregnant, parturient or breast-feeding woman;
- Subject deprived of freedom by judicial, medical or administrative decision;
- Underage subject;
- Subject is legally protected or unable to express his/her consent;
- Subject not affiliated with or not a beneficiary of a social security scheme;
- Subject falling into several categories above;
- Subject who refused to participate in the study;
- Subject participating in an treatment clinical study;
- Subject who, according to the investigator, has cognitive problems that prevent him/her from completing a questionnaire or for whom the assessment may be a problem.
The study team makes the final eligibility decision.
Where it's taking place
- Leuven, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Leuven, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.